Journal of Hematology & Oncology

Celebrating a decade of the Journal of Hematology & Oncology

2018 marks the 10 year anniversary since the Journal of Hematology & Oncology published its first article. Over the past decade, the journal has established itself in the top quartile of journals in both its fields worldwide.

To mark this occasion, we're looking back at the journal's milestone achievements and highlighting some of the best content from the past 10 years.

Content type: Review
| 15 June 2018

NF-κB signaling and its relevance to the treatment of mantle cell lymphoma

Authors: Swathi Balaji, Makhdum Ahmed, Elizabeth Lorence, Fangfang Yan, Krystle Nomie and Michael Wang
Content type: Research
| 14 June 2018

Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties

Authors: Shihua Wang, Meiqian Xu, Xiaoxia Li, Xiaodong Su, Xian Xiao, Armand Keating and Robert Chunhua Zhao
Content type: Review
| 11 June 2018

Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer

Authors: Anishka D’Souza, Darcy Spicer and Janice Lu
Content type: Letter to the Editor
| 11 June 2018

Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study

Authors: Gianluigi Reda, Bruno Fattizzo, Ramona Cassin, Veronica Mattiello, Tatiana Tonella, Diana Giannarelli, Ferdinando Massari and Agostino Cortelezzi
Content type: Research highlight
| 7 June 2018

Basket trial of TRK inhibitors demonstrates efficacy in TRK fusion-positive cancers

Authors: Yu Chen and Ping Chi

Most recent articles RSS

View all articles

Content type: Review
| 22 March 2011

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

Authors: Gerhard J Molderings, Stefan Brettner, Jürgen Homann and Lawrence B Afrin
Content type: Review
| 10 June 2009

The effects of β-glucan on human immune and cancer cells

Authors: Godfrey Chi-Fung Chan, Wing Keung Chan and Daniel Man-Yuen Sze
Content type: Review
| 25 February 2013

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Authors: Xinyuan Li, Pu Fang, Jietang Mai, Eric T Choi, Hong Wang and Xiao-feng Yang
Content type: Review
| 19 August 2013

Ibrutinib and novel BTK inhibitors in clinical development

Authors: Akintunde Akinleye, Yamei Chen, Nikhil Mukhi, Yongping Song and Delong Liu
Content type: Review
| 30 September 2013

The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies

Authors: Li Shi, Shaohua Chen, Lijian Yang and Yangqiu Li

Most accessed articles RSS

View all articles

Featured series: Recent development in cancer immunotherapy

Aims and scope

Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology.

Experimental Hematology & Oncology

Submit your research to our companion journal, Experimental Hematology & Oncology

Editor's quote

"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."

Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology

Research highlights

Journal of Hematology & Oncology is now publishing research highlights – commentaries on recently published work that place the new research in the context of the current literature.

Journal of Hematology & Oncology

Celebrating a decade of the Journal of Hematology & Oncology

Articles

NF-κB signaling and its relevance to the treatment of mantle cell lymphoma

Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties

Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer

Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study

Basket trial of TRK inhibitors demonstrates efficacy in TRK fusion-positive cancers

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

The effects of β-glucan on human immune and cancer cells

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Ibrutinib and novel BTK inhibitors in clinical development

The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies

Featured series: Recent development in cancer immunotherapy

Aims and scope

Experimental Hematology & Oncology

Editor's quote

Research highlights

Official journal of

2016 Journal Metrics

Journal of Hematology & Oncology

Contact us